Antiviral drugs in the immunocompetent host: part II. Treatment of influenza and respiratory syncytial virus infections.
Family physicians should be familiar with the various drugs available for treating and preventing viral infections. Part II of this two-part article focuses on agents used to manage influenza and respiratory syncytial virus. Rimantadine and amantadine traditionally have been used to prevent and treat influenza type A infections. The neuraminidase inhibitors zanamivir and oseltamivir have a broadened spectrum of activity in the treatment and prevention of influenza types A and B. Ribavirin has been used in some high-risk infants to treat respiratory syncytial virus infections, and palivizumab can be used for prophylaxis.
Colgan
Richard
R
University of Maryland School of Medicine, Baltimore, Maryland, USA.
Michocki
Robert
R
Greisman
Lisa
L
Moore
Tracy A Wolff
TA
D000998:Antiviral Agents / Q000627:therapeutic use*; D006801:Humans; D007121:Immunocompetence; D007251:Influenza, Human / Q000188:drug therapy*; D018357:Respiratory Syncytial Virus Infections / Q000188:drug therapy*
D000998:Antiviral Agents